EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
September 30, 2026 -0.7859
June 30, 2026 0.1476
March 31, 2026 0.7795
December 31, 2025 0.9771
September 30, 2025 -0.4666
June 30, 2025 -0.434
March 31, 2025 -0.5763
December 31, 2024 -0.5408
September 30, 2024 -0.5562
June 30, 2024 -0.9672
March 31, 2024 -0.6324
December 31, 2023 -0.1452
September 30, 2023 -0.6006
June 30, 2023 -0.5935
March 31, 2023 -0.5364
December 31, 2022 2.051
September 30, 2022 -0.2783
June 30, 2022 -0.4918
March 31, 2022 -0.5263
December 31, 2021 -0.4001
September 30, 2021 -0.3632
June 30, 2021 -0.4584
March 31, 2021 -0.5666
December 31, 2020 -0.6045
September 30, 2020 -0.6605
Date Value
June 30, 2020 -0.6108
March 31, 2020 -0.5346
December 31, 2019 -0.5773
September 30, 2019 -0.3334
June 30, 2019 -0.2944
March 31, 2019 -0.4967
December 31, 2018 -0.4802
September 30, 2018 -0.8114
June 30, 2018 -0.6964
March 31, 2018 -0.6224
December 31, 2017 -0.3446
September 30, 2017 -0.1617
June 30, 2017 -0.3261
March 31, 2017 -0.3443
December 31, 2016 -0.45
September 30, 2016 -0.34
June 30, 2016 -0.32
March 31, 2016 -0.54
December 31, 2015 -0.52
September 30, 2015 -0.53
June 30, 2015 -0.44
March 31, 2015 -0.51
December 31, 2014 -0.61
September 30, 2014 -0.54
June 30, 2014 -0.53

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. 7.221
Aytu BioPharma, Inc. -0.2008
Daré Bioscience, Inc. -0.1813
Jaguar Health, Inc. -9.226
Structure Therapeutics, Inc. -1.992